| |
|
|
Articaine Intermediates |
|
3-Amino-4-methyl-2-thiophene carboxylic acid methyl ester |
|
Pyrantel Intermediates |
|
1,2-Dimethyl-1,4,5,6-tetrahydropyrimidine |
|
3-Methylaminopropylamine |
|
Venlafaxine Intermediates |
|
1-(2-Amino-1-(4-methoxyphenyl)ethyl) cyclohexanol hydrochloride |
| |
Carisoprodol Intermediates |
 |
N-isoproply-2-methyl-2-proply-3-idrossipropyl carbamate |
|
5-methyl-5-propyl-1,3-dioxan-2-one |
|
|
 |
 Land : 33,300M2 |
Building: 45,000M2 |
| Total reactor volume: 95,000 M3, ranging from 20L to 6,300L |
| Rich Process Experience: |
|
| ·Catalystic Hydrogenation |
·Cyanation |
·Fluorination |
| ·Grignard Reaction |
·Knoevenagel Reaction |
·Schiff Base Reaction |
| ·Stobbe Reaction |
·Claisen Condensation |
·Ultra-low temperature reaction |
| ·Chlorination |
·Diazotation |
·Beckmann rearrangement |
| ·Friedel-Crafts reaction |
·Semmler wolff reaction |
·Transesterification |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
| |
|
| |
|
|
|
|
